The SIRPAC study, presented at EuroPCR 2020 as late-breaking clinical trial, was accepted for publication in Cardiovascular Revascularization Medicine. Stay tuned!

First comparison of paclitaxel vs. sirolimus DCB published
Leave a comment
You must be logged in to post a comment.